Ft. Pierce, FL, United States of America

John K Reed


Average Co-Inventor Count = 3.7

ph-index = 1


Location History:

  • Ft. Pierce, FL (US) (2005 - 2006)
  • Fort Pierce, FL (US) (2004 - 2009)

Company Filing History:


Years Active: 2004-2009

Loading Chart...
4 patents (USPTO):Explore Patents

Title: John K Reed: Innovator in Biologically Active Compounds

Introduction

John K Reed is a notable inventor based in Ft. Pierce, FL (US). He has made significant contributions to the field of biologically active compounds, particularly in the context of cancer treatment. With a total of 4 patents, Reed's work has the potential to impact medical science and therapeutic applications.

Latest Patents

Reed's latest patents include groundbreaking inventions such as the "Antiproliferative activity of the leiodermatolide class of macrolides." This invention provides novel biologically active compounds that are useful in inhibiting cellular proliferation. The pharmaceutical compositions derived from these compounds can be utilized in cancer treatment. Another significant patent is titled "Lactone compounds and methods of use," which offers compositions of biologically active compounds aimed at inhibiting pathological cellular proliferation, also with applications in cancer treatment.

Career Highlights

Throughout his career, John K Reed has worked with esteemed organizations such as Harbor Branch Oceanographic Institution, Inc. and Florida Atlantic University. His work in these institutions has allowed him to explore and develop innovative solutions in the field of biological sciences.

Collaborations

Reed has collaborated with notable colleagues, including Amy E Wright and Ross E Longley. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

John K Reed's contributions to the field of biologically active compounds highlight his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to finding solutions for critical health challenges, particularly in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…